Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs

The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial fibrillation and a number of other conditions requi...

Full description

Bibliographic Details
Main Authors:	B. A. Tatarsky, N. V. Kazyonnova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-08-01
Series:	Российский кардиологический журнал
Subjects:	drug-drug interactions direct oral anticoagulants antiarrhythmic drugs atrial fibrillation cytochrome p450 glycoprotein p
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4482

Similar Items

Comparing monopharmacotherapy of antiarrhythmic and anticoagulant drugs with other drugs for atrial fibrillation: A complete review of clinical trials
by: Akshat D. Modi, et al.
Published: (2023-06-01)

Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study
by: Victor Chien‐Chia Wu, et al.
Published: (2024-11-01)

Safety issues of antiarrhythmic therapy for atrial fibrillation
by: I.I. Reznik, et al.
Published: (2024-01-01)

Pharmacologic Therapy in the Elderly with Atrial Fibrillation
by: Shih-Huang Lee, et al.
Published: (2008-03-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
by: Koichiro Kumagai, MD, et al.
Published: (2011-01-01)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
by: Jonathan G. Tardos, et al.
Published: (2021-03-01)

The current approach of atrial fibrillation management
by: Anish Amin, et al.
Published: (2016-01-01)

Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
by: Takashi Komatsu
Published: (2012-06-01)

Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF) – Report on antiarrhythmic drug therapy
by: Yuji Murakawa, MD, et al.
Published: (2014-10-01)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
by: Inseok Hwang, et al.
Published: (2021-05-01)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
by: Inseok Hwang, et al.
Published: (2022-12-01)

Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects
by: M. G Bubnova, et al.
Published: (2015-09-01)

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO
by: R. D. Kurbanov, et al.
Published: (2020-12-01)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
by: Meng Geng, et al.
Published: (2020-11-01)

Avoiding anticoagulation drugs for postoperative atrial fibrillation enabled successful conservative treatment of left atrial dissection: a case report
by: Kentaro Kiryu, et al.
Published: (2021-05-01)

A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation
by: Morten Lock Hansen, et al.
Published: (2024-07-01)

In Vitro Inhibitory Effects of Scutellarin on Six Human/Rat Cytochrome P450 Enzymes and P-glycoprotein
by: Yong-Long Han, et al.
Published: (2014-05-01)

Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers
by: Dal-Sik Kim, et al.
Published: (2016-10-01)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
by: Yunwen Xu, et al.
Published: (2022-07-01)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry
by: Ruben Schleberger, et al.
Published: (2021-12-01)

Comparison of the 11-Day Adhesive ECG Patch Monitor and 24-h Holter Tests to Assess the Response to Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation
by: Soohyun Kim, et al.
Published: (2023-09-01)

Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles
by: Marco Valerio Mariani, et al.
Published: (2024-08-01)

Herbal Medicines in Brazil: Pharmacokinetic Profile and Potential Herb-Drug Interactions
by: Andre Luis Dias Araujo Mazzari, et al.
Published: (2014-07-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels
by: Antonius Ratte, et al.
Published: (2019-11-01)

The efficacy of synchronized direct current shock in reverting long standing persistent atrial fibrillation in to sinus rhythm. What help to achieve high success rate?
by: AMAR Talib AL-HAMDI, et al.
Published: (2021-05-01)

AIM‐AF: A Physician Survey in the United States and Europe
by: A. John Camm, et al.
Published: (2022-03-01)

Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data
by: Woojin Kim, et al.
Published: (2023-01-01)

Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report
by: Yuki Miyata, et al.
Published: (2025-01-01)

Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry
by: A. Vora, et al.
Published: (2017-01-01)

Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation
by: Aurélie Lenglet, et al.
Published: (2022-12-01)

Ablation and antiarrhythmic drug effects on PITX2+/− deficient atrial fibrillation: A computational modeling study
by: Ze Jin, et al.
Published: (2022-07-01)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective
by: Malte Kuniss, et al.
Published: (2024-11-01)

Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
by: Sabine F. B. van der Horst, et al.
Published: (2023-07-01)

Spatial Changes in the Atrial Fibrillation Wave-Dynamics After Using Antiarrhythmic Drugs: A Computational Modeling Study
by: Inseok Hwang, et al.
Published: (2021-09-01)

Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin
by: Kyeong‐Hyeon Chun, et al.
Published: (2024-08-01)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
by: Seo Yeon Yoo, et al.
Published: (2022-05-01)

Corrigendum: Spatial changes in the atrial fibrillation wave-dynamics after using antiarrhythmic drugs: A computational modeling study
by: Inseok Hwang, et al.
Published: (2022-12-01)

Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug–Drug Interaction Study
by: Irene Moreno, et al.
Published: (2024-04-01)